Population-based modeling improves treatment planning before 90Y-labeled anti-CD66 antibody radioimmunotherapy

For treatment planning in radioimmunotherapy (RIT), the accurate estimation of time-integrated activity coefficients (TIACs) is essential. To estimate the TIACs in RIT using 90Y-labeled anti-CD66 antibodies, physiologically based pharmacokinetic (PBPK) models are advantageous. Further optimization i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Maaß, Christian (VerfasserIn) , Glatting, Gerhard (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 9 Sep 2015
In: Cancer biotherapy and radiopharmaceuticals
Year: 2015, Jahrgang: 30, Heft: 7, Pages: 285-290
ISSN:1557-8852
DOI:10.1089/cbr.2015.1878
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1089/cbr.2015.1878
Verlag, Volltext: https://online-liebertpub-com.ezproxy.medma.uni-heidelberg.de/doi/10.1089/cbr.2015.1878
Volltext
Verfasserangaben:Christian Maaß, Peter Kletting, Donald Bunjes, Bettina Mahren, Ambros J. Beer, and Gerhard Glatting

MARC

LEADER 00000caa a2200000 c 4500
001 157057118X
003 DE-627
005 20230428184819.0
007 cr uuu---uuuuu
008 180306s2015 xx |||||o 00| ||eng c
024 7 |a 10.1089/cbr.2015.1878  |2 doi 
035 |a (DE-627)157057118X 
035 |a (DE-576)50057118X 
035 |a (DE-599)BSZ50057118X 
035 |a (OCoLC)1340994001 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Maaß, Christian  |d 1989-  |e VerfasserIn  |0 (DE-588)1075073235  |0 (DE-627)832913936  |0 (DE-576)443238464  |4 aut 
245 1 0 |a Population-based modeling improves treatment planning before 90Y-labeled anti-CD66 antibody radioimmunotherapy  |c Christian Maaß, Peter Kletting, Donald Bunjes, Bettina Mahren, Ambros J. Beer, and Gerhard Glatting 
264 1 |c 9 Sep 2015 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 06.03.2018 
520 |a For treatment planning in radioimmunotherapy (RIT), the accurate estimation of time-integrated activity coefficients (TIACs) is essential. To estimate the TIACs in RIT using 90Y-labeled anti-CD66 antibodies, physiologically based pharmacokinetic (PBPK) models are advantageous. Further optimization in predicting therapeutic TIACs may be achieved by including population-specific parameters. Therefore, the aims of this work were (1) to estimate population parameters and (2) to show the effect of these parameters on prediction accuracy of therapeutic biodistributions. To estimate population values, a PBPK model was fitted to pretherapeutic (gamma camera and serum) and therapeutic (serum) measurements simultaneously using the standard two-stage (STS) and iterated two-stage (ITS) algorithms. Including the estimated population values as Bayesian information, the model parameters of each patient were fitted to pretherapeutic data only (simulating therapeutic TIACs). To validate the prediction accuracy of the therapeutic serum curve, the simulated and fitted TIACs were compared. Prediction accuracy expressed as relative deviation (RD) improved from RD=8%±16% to RD=0%±10% for STS and ITS, respectively. The authors demonstrated a method to estimate and apply population values for RIT using a PBPK model and population fitting. For 90Y-labeled anti-CD66 antibodies, the prediction accuracy was substantially improved. 
700 1 |a Glatting, Gerhard  |d 1961-  |e VerfasserIn  |0 (DE-588)1055963103  |0 (DE-627)792987675  |0 (DE-576)411974521  |4 aut 
773 0 8 |i Enthalten in  |t Cancer biotherapy and radiopharmaceuticals  |d Larchmont, NY : Liebert, 1996  |g 30(2015), 7, Seite 285-290  |h Online-Ressource  |w (DE-627)324660154  |w (DE-600)2029859-6  |w (DE-576)255072864  |x 1557-8852  |7 nnas  |a Population-based modeling improves treatment planning before 90Y-labeled anti-CD66 antibody radioimmunotherapy 
773 1 8 |g volume:30  |g year:2015  |g number:7  |g pages:285-290  |g extent:6  |a Population-based modeling improves treatment planning before 90Y-labeled anti-CD66 antibody radioimmunotherapy 
856 4 0 |u http://dx.doi.org/10.1089/cbr.2015.1878  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://online-liebertpub-com.ezproxy.medma.uni-heidelberg.de/doi/10.1089/cbr.2015.1878  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180306 
993 |a Article 
994 |a 2015 
998 |g 1055963103  |a Glatting, Gerhard  |m 1055963103:Glatting, Gerhard  |d 60000  |d 63000  |e 60000PG1055963103  |e 63000PG1055963103  |k 0/60000/  |k 1/60000/63000/  |p 6  |y j 
999 |a KXP-PPN157057118X  |e 3001862602 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"157057118X","language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 06.03.2018"],"person":[{"family":"Maaß","given":"Christian","roleDisplay":"VerfasserIn","display":"Maaß, Christian","role":"aut"},{"family":"Glatting","given":"Gerhard","display":"Glatting, Gerhard","roleDisplay":"VerfasserIn","role":"aut"}],"title":[{"title":"Population-based modeling improves treatment planning before 90Y-labeled anti-CD66 antibody radioimmunotherapy","title_sort":"Population-based modeling improves treatment planning before 90Y-labeled anti-CD66 antibody radioimmunotherapy"}],"relHost":[{"origin":[{"publisherPlace":"Larchmont, NY","dateIssuedDisp":"1996-","publisher":"Liebert","dateIssuedKey":"1996"}],"title":[{"title_sort":"Cancer biotherapy and radiopharmaceuticals","title":"Cancer biotherapy and radiopharmaceuticals"}],"id":{"issn":["1557-8852"],"eki":["324660154"],"zdb":["2029859-6"]},"physDesc":[{"extent":"Online-Ressource"}],"disp":"Population-based modeling improves treatment planning before 90Y-labeled anti-CD66 antibody radioimmunotherapyCancer biotherapy and radiopharmaceuticals","type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"recId":"324660154","pubHistory":["11.1996 -"],"part":{"issue":"7","pages":"285-290","year":"2015","extent":"6","text":"30(2015), 7, Seite 285-290","volume":"30"}}],"physDesc":[{"extent":"6 S."}],"name":{"displayForm":["Christian Maaß, Peter Kletting, Donald Bunjes, Bettina Mahren, Ambros J. Beer, and Gerhard Glatting"]},"id":{"eki":["157057118X"],"doi":["10.1089/cbr.2015.1878"]},"origin":[{"dateIssuedDisp":"9 Sep 2015","dateIssuedKey":"2015"}]} 
SRT |a MAASSCHRISPOPULATION9201